Last reviewed · How we verify
CXL-1427 Ascending Dose
At a glance
| Generic name | CXL-1427 Ascending Dose |
|---|---|
| Also known as | BMS-986231 |
| Sponsor | Bristol-Myers Squibb |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CXL-1427 Ascending Dose CI brief — competitive landscape report
- CXL-1427 Ascending Dose updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI